HSDDHypoactive Sexual Desire Disorder
HSDDHigh Speed Digital Design
HSDDHigh-Speed Digital Design
HSDDHistorical Stock Data Downloader (Semaj Software)
HSDDHardware/Software Design and Development (est. 1985; Brecksville, OH)
HSDDHigh School Drama Department
HSDDHealth Systems Development Division (Seychelles and Canada)
References in periodicals archive ?
Fosun's significant resources and commercial capabilities are uniquely suited to raise awareness and understanding of HSDD and the potential benefits of bremelanotide to health care providers and patients.
Clayton said the causes of HSDD in the study cohort were "biologically based" but that hypoactive sexual desire disorder is a biopsychosocial condition.
Thus, HSDD is a real and important component of overall health and well-being.
I direct a menopause and sexual health clinic, and have prescribed flibanserin to approximately 15 pre-menopausal women with diagnosed acquired, generalized HSDD over the last 4 months after discussion of the data, the interaction with alcohol, drug interactions, and potential side effects.
Prior to the FDA approval of flibanserin, women suffering with HSDD had only untested, unstudied compounded and off-label treatment options with unproven benefits and uncertain risks.
The efficacy of flibanserin for treating HSDD was established in three 24-week, randomized, double-blind, placebo-controlled studies (Table 2, page 62).
Now comes the little pink pills with the curious HSDD indication.
In total, 67 women with HSDD were randomly assigned to received Tribulus terrestris 7.
05, with the majority of the participants (87% asexual, 88% HSDD, 80% low desire, 89% comparison) having received at least some post-secondary education.
Mindful that the diagnosis and treatment of HSDD routinely acts as a medicalizing, regulatory force governing (primarily heterosexual) women's sexuality, it is crucial to unpack the "safe" definition of asexuality and the binary it supports.
The authors state "Sildenafil improves HSDD associated with selective serotonin reuptake inhibitors," based on a 2008 JAMA article by Nurnberg et al.
By 52 weeks, HSDD symptoms had fallen to remission levels in 90% of the group (J.